Sundström E, Mo L L
Dept. of Clinical Neuroscience and Family Medicine, Karolinska Institutet, Huddinge, Sweden.
Res Commun Mol Pathol Pharmacol. 1995 May;88(2):131-6.
The present study was performed to determine if 1-methyl-4-phenylpyridinium (MPP+) affects binding of 3H-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imi ne maleate ([3H]MK-801), [3H]glutamate and [3H]glycine to the rat and monkey striatal N-methyl-D-aspartate (NMDA) receptor. We found that MPP+ non-competitively inhibits [3H]MK-801 binding with IC50 values between 80 and 330 microM depending on the species and the concentration of glutamate and glycine. MPP+ also partially inhibited [3H]glycine binding without affecting [3H]glutamate binding. We conclude that MPP+ is not an agonist at the NMDA receptor but at high concentrations inhibits NMDA receptor function.
本研究旨在确定1-甲基-4-苯基吡啶鎓(MPP+)是否会影响[3H](-)-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺马来酸盐([3H]MK-801)、[3H]谷氨酸盐和[3H]甘氨酸与大鼠和猴纹状体N-甲基-D-天冬氨酸(NMDA)受体的结合。我们发现,MPP+以非竞争性方式抑制[3H]MK-801结合,IC50值在80至330微摩尔之间,具体取决于物种以及谷氨酸盐和甘氨酸的浓度。MPP+还部分抑制[3H]甘氨酸结合,而不影响[3H]谷氨酸盐结合。我们得出结论,MPP+不是NMDA受体的激动剂,但在高浓度下会抑制NMDA受体功能。